- Home
- SNY vs MCK Comparison
SNY vs MCK Comparison
Compare SNY & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- MCK
- Stock Information
- Founded
- SNY 1994
- MCK 1833
- Country
- SNY France
- MCK United States
- Employees
- SNY N/A
- MCK N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- MCK Other Pharmaceuticals
- Sector
- SNY Health Care
- MCK Health Care
- Exchange
- SNY Nasdaq
- MCK Nasdaq
- Market Cap
- SNY 116.1B
- MCK 104.4B
- IPO Year
- SNY N/A
- MCK N/A
- Fundamental
- Price
- SNY $52.02
- MCK $853.28
- Analyst Decision
- SNY Buy
- MCK Strong Buy
- Analyst Count
- SNY 4
- MCK 12
- Target Price
- SNY $61.50
- MCK $876.25
- AVG Volume (30 Days)
- SNY 2.3M
- MCK 687.0K
- Earning Date
- SNY 10-24-2025
- MCK 11-05-2025
- Dividend Yield
- SNY 3.07%
- MCK 0.39%
- EPS Growth
- SNY 105.93
- MCK 66.19
- EPS
- SNY 8.67
- MCK 32.12
- Revenue
- SNY $53,890,648,839.00
- MCK $387,094,000,000.00
- Revenue This Year
- SNY $2.37
- MCK $14.98
- Revenue Next Year
- SNY $6.51
- MCK $8.22
- P/E Ratio
- SNY $11.84
- MCK $26.22
- Revenue Growth
- SNY N/A
- MCK 17.23
- 52 Week Low
- SNY $44.62
- MCK $558.13
- 52 Week High
- SNY $60.12
- MCK $867.63
- Technical
- Relative Strength Index (RSI)
- SNY 63.05
- MCK 66.60
- Support Level
- SNY $48.55
- MCK $836.95
- Resistance Level
- SNY $52.68
- MCK $867.63
- Average True Range (ATR)
- SNY 0.68
- MCK 21.69
- MACD
- SNY 0.15
- MCK -1.28
- Stochastic Oscillator
- SNY 84.28
- MCK 83.04
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About MCK McKesson Corporation
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.